Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 205935
Company: SANDOZ
Company: SANDOZ
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | AO | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/14/2019 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/19/2021 | SUPPL-6 | Labeling-Package Insert |
Label is not available on this site. |
||
03/19/2021 | SUPPL-5 | Labeling-Package Insert |
Label is not available on this site. |
||
03/19/2021 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
||
03/19/2021 | SUPPL-2 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label is not available on this site. |
FULVESTRANT
SOLUTION;INTRAMUSCULAR; 250MG/5ML (50MG/ML)
TE Code = AO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
FASLODEX | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | Yes | AO | 021344 | ASTRAZENECA |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 211689 | ACCORD HLTHCARE |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 215077 | ALEMBIC |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 210044 | AMNEAL |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 211422 | CHIA TAI TIANQING |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 209246 | DR REDDYS |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 208811 | EUGIA PHARMA |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 215169 | EUGIA PHARMA |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 210326 | FRESENIUS KABI USA |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 207754 | GLENMARK PHARMS INC |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 209714 | HBT LABS INC |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 214682 | JIANGSU HANSOH PHARM |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 205871 | SAGENT PHARMS INC |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 205935 | SANDOZ |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 213553 | XIROMED |
FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription | No | AO | 215234 | ZYDUS PHARMS |